Rapid antimicrobial susceptibility determination of uropathogens in clinical urine specimens by use of ATP bioluminescence

Journal of Clinical Microbiology

Volumn 46, Issue 4, 2008, Pages 1213-1219

  Ivančić, Vesna ^a   Mastali, Mitra ^a   Percy, Neil ^b   Gornbein, Jeffrey ^a   Babbitt, Jane T ^a   Li, Yang ^a   Landaw, Elliot M ^a   Bruckner, David A ^a   Churchill, Bernard M ^a   Haake, David A ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Hygiena   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d Section of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CEFALOTIN; CIPROFLOXACIN; GENTAMICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIOLUMINESCENCE; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; PRIORITY JOURNAL; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; ANTIBIOTIC RESISTANCE; BACTERIUM; DRUG EFFECT; ENZYMOLOGY; EVALUATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LUMINESCENCE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; TIME; URINE;

BACTERIA (MICROORGANISMS);

ADENOSINE TRIPHOSPHATE; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LUMINESCENT MEASUREMENTS; MICROBIAL SENSITIVITY TESTS; TIME FACTORS; URINARY TRACT INFECTIONS; URINE;

EID: 42449160632     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02036-07     Document Type: Article

References (32)

1. Chappelle, E. W., and G. V. Levin. 1968. Use of the firefly bioluminescent reaction for rapid detection and counting of bacteria. Biochem. Med. 2:41-52.
2. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, seventh edition. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Conn, R. B., P. Charache, and E. W. Chappelle. 1975. Limits of applicability of the firefly luminescence ATP assay for the detection of bacteria in clinical specimens. Am. J. Clin. Pathol. 63:493-501.
5. Czaja, C. A., D. Scholes, T. M. Hooton, and W. E. Stamm. 2007. Population-based epidemiologic analysis of acute pyelonephritis. Clin. Infect. Dis. 45:273-280.
6. Drow, D. L., C. H. Baum, and G. Hirschfield. 1984. Comparison of the Lumac and Monolight systems for detection of bacteriuria by bioluminescence. J. Clin. Microbiol. 20:797-801.
7. Dyer, I. E., T. M. Sankary, and J. A. Dawson. 1998. Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997. West. J. Med. 169:265-268.
8. Foxman, B., R. Barlow, H. D'Arcy, B. Gillespie, and J. D. Sobel. 2000. Urinary tract infection: self-reported incidence and associated costs. Ann. Epidemiol. 10:509-515.
9. Gupta, K. 2003. Emerging antibiotic resistance in urinary tract pathogens. Infect. Dis. Clin. N. Am. 17:243-259.
10. Hanberger, H., L. E. Nilsson, E. Kihlstrom, and R. Maller. 1990. Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP. Antimicrob. Agents Chemother. 34:102-106.
11. Hattori, N., M. O. Nakajima, K. O'Hara, and T. Sawai. 1998. Novel antibiotic susceptibility tests by the ATP-bioluminescence method using filamentous cell treatment. Antimicrob. Agents Chemother. 42:1406-1411.
12. Kolbeck, J. C., R. A. Padgett, E. G. Estevez, and L. J. Harrell. 1985. Bioluminescence screening for bacteriuria. J. Clin. Microbiol. 21:527-530.
13. Kunin, C. 1997. Diagnostic methods, p. 42-77. In Urinary tract infections: detection, prevention, and management, 5th ed. The Williams & Wilkins Co., Baltimore, MD.
14. Mackett, D., S. Kessock-Philip, S. Bascomb, and C. S. Easmon. 1982. Evaluation of the Lumac kit for the detection of bacteriuria by bioluminescence. J. Clin. Pathol. 35:107-110.
15. McWalter, P. W. 1984. Determination of susceptibility of Staphylococcus aureus to methicillin by luciferin-luciferase assay of bacterial adenosine triphosphate. J. Appl. Bacteriol. 56:145-150.
16. Nichols, W. W., G. D. Curtis, and H. H. Johnston. 1982. Analysis of the disagreement between automated bioluminescence-based and culture methods for detecting significant bacteriuria, with proposals for standardizing evaluations of bacteriuria detection methods. J. Clin. Microbiol. 15:802-809.
17. Nicolle, L. 2001. Epidemiology of urinary tract infection. Infect. Med. 18:153-162.
18. Odenholt, I., B. Isaksson, L. Nilsson, and O. Cars. 1989. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 8:136-141.
19. Salyers, A. A., and D. D. Whitt. 2005. Revenge of the microbes: how bacterial resistance is undermining the antibiotic miracle. American Society for Microbiology Press, Washington, DC.
20. Schappert, S. M. 1999. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States. 1997. Vital Health Stat. 13:i-iv, 1-39.
21. Selan, L., F. Berlutti, C. Passariello, M. C. Thaller, and G. Renzini. 1992. Reliability of a bioluminescence ATP assay for detection of bacteria. J. Clin. Microbiol. 30:1739-1742.
22. Semeniuk, H., J. Noonan, H. Gill, and D. Church. 2002. Evaluation of the Coral UTI Screen system for rapid automated screening of significant bacteriuria in a regional centralized laboratory. Diagn. Microbiol. Infect. Dis. 44:7-10.
23. Spellberg, B., J. H. Powers, E. P. Brass, L. G. Miller, and J. E. Edwards, Jr. 2004. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38:1279-1286.
24. Talan, D. A., W. E. Stamm, T. M. Hooton, G. J. Moran, T. Burke, A. Iravani, J. Reuning-Scherer, and D. A. Church. 2000. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 283:1583-1590.
25. Thore, A., S. Ansehn, A. Lundin, and S. Bergman. 1975. Detection of bacteriuria by luciferase assay of adenosine triphosphate. J. Clin. Microbiol. 1:1-8.
26. Thore, A., A. Lundin, and S. Ansehn. 1983. Firefly luciferase ATP assay as a screening method for bacteriuria. J. Clin. Microbiol. 17:218-224.
27. Thore, A., L. Nilsson, H. Hojer, S. Ansehn, and L. Brote. 1977. Effects of ampicillin on intracellular levels of adenosine triphosphate in bacterial cultures related to antibiotic susceptibility. Acta Pathol. Microbiol. Scand. Sect. B 85:161-166.
28. Warren, J. W., E. Abrutyn, J. R. Hebel, J. R. Johnson, A. J. Schaeffer, W. E. Stamm, et al. 1999. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin. Infect. Dis. 29:745-758.
29. Welch, W. D., M. A. Layman, and P. M. Southern, Jr. 1984. Evaluation of the MS-2 and Lumac systems for the rapid screening of urine specimens. Am. J. Clin. Pathol. 81:629-633.
30. Welch, W. D., L. Thompson, M. Layman, and P. M. Southern, Jr. 1984. Evaluation of two bioluminescence-measuring instruments, the Turner design and Lumac systems, for the rapid screening of urine specimens. J. Clin. Microbiol. 20:1165-1170.
31. Wheat, P. F., J. G. Hastings, and R. C. Spencer. 1988. Rapid antibiotic susceptibility tests on Enterobacteriaceae by ATP bioluminescence. J. Med. Microbiol. 25:95-99.
32. Wheat, P. F., R. C. Spencer, and J. G. Hastings. 1989. A novel luminometer for rapid antimicrobial susceptibility tests on gram-positive cocci by ATP bioluminescence. J. Med. Microbiol. 29:277-282.